Blockchain Registration Transaction Record

New Review Offers Roadmap for Managing Childhood Neuroblastoma

Comprehensive review of neuroblastoma management covers risk classification, surgery, immunotherapy, and survivorship, offering a practical roadmap for pediatric specialists.

This review matters because it provides a unified, evidence-based framework for clinicians dealing with neuroblastoma, a disease with highly variable outcomes. By clarifying how risk factors like MYCN amplification and staging influence treatment, it helps avoid unnecessary therapy in low-risk patients while ensuring high-risk patients receive aggressive, coordinated care. The emphasis on long-term survivorship and standardized reporting could lead to better international collaboration and improved quality of life for survivors, ultimately guiding clinical decisions and future research.